406 related articles for article (PubMed ID: 28967900)
1. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J
Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma.
Calles A; Sholl LM; Rodig SJ; Pelton AK; Hornick JL; Butaney M; Lydon C; Dahlberg SE; Oxnard GR; Jackman DM; Jänne PA
Clin Cancer Res; 2015 Jun; 21(12):2851-60. PubMed ID: 25737507
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic liver kinase B1 promotes the growth of human lung adenocarcinoma by enhancing autophagy.
Liu M; Jiang L; Fu X; Wang W; Ma J; Tian T; Nan K; Liang X
Cancer Sci; 2018 Oct; 109(10):3055-3067. PubMed ID: 30033530
[TBL] [Abstract][Full Text] [Related]
5. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
6. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
8. Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer.
Wang J; Hu T; Wang Q; Chen R; Xie Y; Chang H; Cheng J
Cancer Lett; 2021 Jul; 509():89-104. PubMed ID: 33848520
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells.
Dong LX; Sun LL; Zhang X; Pan L; Lian LJ; Chen Z; Zhong DS
Acta Pharmacol Sin; 2013 Feb; 34(2):314-8. PubMed ID: 23178462
[TBL] [Abstract][Full Text] [Related]
10. The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.
Rodón L; Svensson RU; Wiater E; Chun MGH; Tsai WW; Eichner LJ; Shaw RJ; Montminy M
Sci Adv; 2019 Jul; 5(7):eaaw6455. PubMed ID: 31355336
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
Chen Y; Liu Y; Zhou Y; You H
Oncol Rep; 2019 Feb; 41(2):1035-1044. PubMed ID: 30483811
[TBL] [Abstract][Full Text] [Related]
12. LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective.
Ciccarese F; Zulato E; Indraccolo S
Oxid Med Cell Longev; 2019; 2019():8730816. PubMed ID: 31781355
[TBL] [Abstract][Full Text] [Related]
13. Mir-451 inhibits proliferation and migration of non-small cell lung cancer cells via targeting LKB1/AMPK.
Liu Y; Li H; Li LH; Tang JB; Sheng YL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):274-280. PubMed ID: 31389598
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
[TBL] [Abstract][Full Text] [Related]
15. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA
J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
[TBL] [Abstract][Full Text] [Related]
18. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
[TBL] [Abstract][Full Text] [Related]
19. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
[TBL] [Abstract][Full Text] [Related]
20. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
Guo C; Hao C; Shao R; Fang B; Correa AM; Hofstetter WL; Roth JA; Behrens C; Kalhor N; Wistuba II; Swisher SG; Pataer A
Oncotarget; 2015 May; 6(13):11114-24. PubMed ID: 25798539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]